Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.
about
Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infectionCholera toxin: a paradigm of a multifunctional proteinRefocusing of B-cell responses following a single amino acid substitution in an antigenRecombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice.A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor.Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant.Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responsesImmunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.The immune responses to bacterial antigens encountered in vivo at mucosal surfaces.Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens.Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections.Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants.Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile.Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.Helicobacter pylori possesses two CheY response regulators and a histidine kinase sensor, CheA, which are essential for chemotaxis and colonization of the gastric mucosaEscherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosely related homologue, the B subunit of cholera toxin.Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentiumExpression of tetanus toxin Fragment C in tobacco chloroplastsReduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxinInduction of cell signaling events by the cholera toxin B subunit in antigen-presenting cellsIntracellular adhesion molecule 1 plays a key role in acquired immunity to salmonellosisConstruction of prokaryotic expression system of ltB-ureB fusion gene and identification of the recombinant protein immunity and adjuvanticity.Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases.Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytesEvaluation of the adjuvant effect of Escherichia coli heat-labile enterotoxin mutant (LTK63) on the systemic immune responses to intranasally co-administered measles virus nucleoprotein. Part I: antibody responses.Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccinesTherapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection.An enzymatically active a domain is required for cholera-like enterotoxins to induce a long-lived blockade on the induction of oral tolerance: new method for screening mucosal adjuvants.Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity.Subunit vaccines based on intimin and Efa-1 polypeptides induce humoral immunity in cattle but do not protect against intestinal colonisation by enterohaemorrhagic Escherichia coli O157:H7 or O26:H-.
P2860
Q24548763-D5101E51-225C-43F5-B891-CEEA2A49F141Q24598726-25049898-7038-4AA5-B528-EAD0305997AFQ28367028-ED7E7B45-543C-4278-8BD1-F147FDD5088FQ30952009-C141E91C-8003-4D1D-A69E-778C6D57190AQ33752525-8D788E8B-D34F-4313-9622-0A6DCDA3E727Q33837275-DA621E2D-6193-458F-9E55-E0781E3D3EACQ33846577-58644111-AE94-4B16-91B0-8520910E30B1Q33866797-044F62E5-1D18-43E1-A340-BA576D2D0CEBQ33955531-9325A8BF-0797-411F-9106-06B144909520Q34000623-F9718473-21C2-4043-9ECE-4D109345557BQ34001509-1B864299-50A9-463D-A8CF-0120167D12B7Q34001658-706263EA-CC76-490A-9105-1F5D147386B0Q34002040-46026533-C5F0-4EA1-A9B6-F46436C89816Q34002470-0244C697-BBCA-4705-87D8-428466CC8B48Q34003888-B636178D-8941-4E3C-AC4B-8EAEE6782670Q34007453-185C4871-18F1-45E0-B9AE-B44593559F34Q34008961-395B2E02-B818-44DB-8FF4-B66098AADEEBQ34771572-49359C0C-CF27-40CD-948A-E199370FFA28Q34975864-B68DD03A-45E4-4DC0-8A39-1E581ED2E3B0Q35559595-C6996519-0521-4ECB-8199-529A2399A9FFQ35913540-6E454363-A914-4E7C-9C76-6B40BEA68A9DQ36044878-456EBF6F-3253-4CE1-AFBF-C93848281530Q36065797-EF2AD189-9177-4D46-8587-3AA067846576Q36217769-EC99EEFC-057A-4611-80D1-0D416BB52C5BQ37191283-6987AE41-4498-4B4B-81AD-439F4E7CF42CQ37247061-5C0A8CFD-D523-4F29-A4AC-5FABE4A9828DQ37590337-707AAF69-B685-4F3B-9BB5-4D7209BFFAA5Q39831682-8353F660-C5FC-454F-B21E-8CF9554156E7Q40404029-997FD44F-C85C-43CC-9D60-2659B3CB26C3Q41855397-463507B4-AB82-4095-AA55-3DB1A2D5FFB1Q42084913-FE6AAAA9-6B4D-4D7D-B2B7-623ECA2C9499
P2860
Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Intranasal immunogenicity and ...... derivatives of cholera toxin.
@ast
Intranasal immunogenicity and ...... derivatives of cholera toxin.
@en
type
label
Intranasal immunogenicity and ...... derivatives of cholera toxin.
@ast
Intranasal immunogenicity and ...... derivatives of cholera toxin.
@en
prefLabel
Intranasal immunogenicity and ...... derivatives of cholera toxin.
@ast
Intranasal immunogenicity and ...... derivatives of cholera toxin.
@en
P2093
P2860
P1476
Intranasal immunogenicity and ...... derivatives of cholera toxin.
@en
P2093
P2860
P304
P407
P577
1997-07-01T00:00:00Z